# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001764013-26-000092
Filing Date
2026-07-22
Accepted
2026-07-22 16:10:12
Documents
20
Period of Report
2026-09-02

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | imvt-20260721.htm iXBRL | DEF 14A | 1088856
6 |  | imvt-20260721_g1.jpg | GRAPHIC | 56364
7 |  | imvt-20260721_g2.jpg | GRAPHIC | 59663
8 |  | imvt-20260721_g3.jpg | GRAPHIC | 53442
9 |  | imvt-20260721_g4.jpg | GRAPHIC | 496560
10 |  | imvt-20260721_g5.jpg | GRAPHIC | 241279
| Complete submission text file | 0001764013-26-000092.txt |  | 3978816

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | imvt-20260721.xsd | EX-101.SCH | 3121
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | imvt-20260721_def.xml | EX-101.DEF | 4776
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | imvt-20260721_lab.xml | EX-101.LAB | 4900
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | imvt-20260721_pre.xml | EX-101.PRE | 4368
23 | EXTRACTED XBRL INSTANCE DOCUMENT | imvt-20260721_htm.xml | XML | 147604

Mailing Address 1000 PARK FORTY PLAZA DURHAM NC 27713
Business Address 1000 PARK FORTY PLAZA DURHAM NC 27713 917-410-3120
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-38906 | Film No.: 261193804
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)